![Cory Freedland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cory Freedland
Director/Board Member at
Palvella Therapeutics, Inc.
Net worth: 582 359 $ as of 31/05/2026
Profile
Cory S.
Freedland is currently Director at Omniox, Inc., Palvella Therapeutics, Inc., Neurogene, Inc. (New York), Nura Bio, Inc., Tentarix Biotherapeutics LP, Tentarix Biotherapeutics, Inc., Nalo Therapeutics, Inc., Covid Apollo Project LLC, Orsobio, Inc., and Independent Director at Neurogene, Inc. since 2023.
Former roles include Director at Rainier Therapeutics, Inc. and Velicept Therapeutics, Inc., Chief Investment Officer & Director at Jiya Acquisition Corp.
from 2020 to 2022, Vice President at Morgan Stanley from 2010 to 2013, Partner at Samsara BioCapital LLC, Analyst at Morgan Stanley & Co. LLC, Principal at Sofinnova Investments, Inc. from 2015 to 2017, Associate at Merrill Lynch, Pierce, Fenner & Smith, Inc. from 2009 to 2010, Principal at Novo Ventures (US), Inc. in 2013, and Principal at Novo Holdings A. Education includes a doctorate from Wake Forest University in 2002, an undergraduate degree from Connecticut College in 1997, and an MBA from Kellogg School of Management in 2009.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.13% | 07/04/2026 | 20,549 ( 0.13% ) | 582 359 $ | 31/05/2026 |
Cory Freedland active positions
| Companies | Position | Start |
|---|---|---|
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices | Director/Board Member | - |
Nura Bio, Inc.
 Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops neuroprotective drugs and therapies | Director/Board Member | - |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Director/Board Member | - |
Nalo Therapeutics, Inc.
 Nalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for cancer patients | Director/Board Member | - |
Tentarix Biotherapeutics, Inc.
 Tentarix Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for intelligent therapies with multifunctional biologics | Director/Board Member | - |
Omniox, Inc.
 Omniox, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for hypoxic diseases | Director/Board Member | - |
Tentarix Biotherapeutics LP
 Tentarix Biotherapeutics LP BiotechnologyHealth Technology Operates as a biotechnology company | Director/Board Member | - |
Covid Apollo Project LLC
 Covid Apollo Project LLC Financial ConglomeratesFinance Operates investment company that funding is based on Covid-19 testing and finding solution | Director/Board Member | - |
OrsoBio Inc
 OrsoBio Inc Miscellaneous Commercial ServicesCommercial Services Develops therapies to treat metabolic disorders and diabetes | Director/Board Member | - |
Former positions of Cory Freedland
| Companies | Position | End |
|---|---|---|
| ░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Cory Freedland
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
22
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 22 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Connecticut College
 Connecticut College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Omniox, Inc.
Omniox, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for hypoxic diseases | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world. | Finance |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer | Health Technology |
Velicept Therapeutics, Inc.
 Velicept Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures biopharmaceutical products | Health Technology |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices | Health Technology |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Health Technology |
Nura Bio, Inc.
Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops neuroprotective drugs and therapies | Health Technology |
Tentarix Biotherapeutics LP
Tentarix Biotherapeutics LP BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Jiya Acquisition Corp.
 Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Tentarix Biotherapeutics, Inc.
Tentarix Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for intelligent therapies with multifunctional biologics | Health Technology |
Nalo Therapeutics, Inc.
Nalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for cancer patients | Health Technology |
Covid Apollo Project LLC
Covid Apollo Project LLC Financial ConglomeratesFinance Operates investment company that funding is based on Covid-19 testing and finding solution | Finance |
OrsoBio Inc
OrsoBio Inc Miscellaneous Commercial ServicesCommercial Services Develops therapies to treat metabolic disorders and diabetes | Commercial Services |
- Stock Market
- Insiders
- Cory Freedland
